Clark Estates’s GSK GSK Stock Holding History
Bought
Maintained
Sold
Other funds holding GSK
Clark Estates's GSK Position: Q3 2022 in Review
Clark Estates sold out of GSK (GSK) in Q3 2022, closing a stake of 260,000 shares — an estimated $14.1M sold.
Clark Estates first reported a position in GSK in Q1 2017 and held it in 21 quarters. The position peaked at $23.4M in Q1 2018. 743 funds tracked by Wall St. Rank hold GSK as of Q3 2022.
- Clark Estates reported no remaining GSK position as of Q3 2022 after selling out during the quarter.
- Clark Estates sold 260,000 GSK shares in Q3 2022, an estimated $14.1M.
- Clark Estates first reported a position in GSK in Q1 2017 and held it in 21 quarters.
- Clark Estates's GSK position peaked at $23.4M in Q1 2018.
- 743 funds tracked by Wall St. Rank held GSK as of Q3 2022.
Based on Clark Estates's 13F filing for Q3 2022, filed 14 Nov 2022.